Delivery Order SPE2DR25D2100-SPE2DR26FA2UG
Award Date 4/2/26
Potential Completion Date 4/23/26
Potential Value $28K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $56,503.68 delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for Ultomiris (pegloticase) 1,100 mg/11 ml vial pharmaceutical supply, with ultimate completion on January 29, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA.</p>
- The Defense Logistics Agency issued a $59,072.02 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 ml vials, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing...
- <p>The Defense Logistics Agency issued a $28,251.84 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Ultomiris 1,100 mg/11 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 21, 2026. Pricing is firm fixed price. No set-aside applies.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $28,251.74 for the supply of Ultomiris 300 mg/3 mL vials. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical...
- <p>The Defense Logistics Agency issued a $28,251.84 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 mL vials under firm fixed-price terms.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 15, 2026. No set-aside applies to this order.</p>
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ultomiris (pegtibatimab alfa), a specialty pharmaceutical product, with a ceiling value of $26,285.85. This firm fixed-price delivery order is set to be completed by August 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency issued a $30,820.18 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for ULTOMIRIS 1,100 mg/11 ml vials, with ultimate completion by April 27, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. Pricing...
- The Defense Logistics Agency awarded a delivery order valued at $32,737.85 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. The delivery order was issued on November 10, 2025, as part of the company's broader federal medical...
- <p>The Defense Logistics Agency issued a $56,503.48 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Ultomiris 300 mg/3 mL vials under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 7, 2026. No set-aside was used in the award.</p>
- The Defense Logistics Agency awarded a $65,921 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegtibetasen alfa, 1,100 mg/11 mL vial) with an ultimate completion date of January 29, 2026. This non-competitive delivery order was issued on January 7, 2026, and represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA2UGDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for Ultomiris (pegloticase) 1,100 mg/11 mL vials with a ceiling value of $28,251.84. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken, PA. The delivery order carries a firm fixed price structure and an ultimate completion date of April 23, 2026.
Generated 7/2/26, 2:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 4/1/26 |